Comparison 14. Topical alpha‐hydroxy acid versus placebo.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 14.1 Withdrawal for any reason | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 14.1.1 gluconolactone versus placebo (long term) | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 14.2 Minor adverse events ‐ total events | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 14.2.1 gluconolactone versus placebo (long term) | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected |